OTCM
DHTRF
Market cap490mUSD
Oct 20, Last price
12.61USD
Name
Dri Healthcare Trust
Chart & performance
P/E
—
P/B
—
EPS
—
Vol. 1Y
—
Shs. 5Y
17.31%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
195m
+40.87%
Net income
-51m
L+1,426.59%
CFO
78m
-49.74%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DRI Healthcare Trust is an unincorporated open-ended company. It engages in the provision of differentiated exposure to the fast-growing pharmaceutical and biotechnology industries through ownership and acquisition of royalties on pharmaceutical products with a focus on delivering attractive growth in cash receipts from royalty assets over the long term. The company was founded in 1989 and is headquartered in Toronto, Canada.
Key people
Trustee, Acting Chief Executive Officer of Manager · since 2024
Tamara Vrooman
Lead Independent Trustee · since 2024
Independent Trustee · since 2021
Independent Trustee · since 2022
Chairman of the Board of Trustee, Chief Executive Officer · since 2024
Annalisa King
Independent Trustee · since 2025
Kevin Layden
Trustee · since 2021
Independent Trustee · since 2021
Headquarters & legal address
1 First Canadian Pl. Suite 6200
100 King St. West
Toronto, ON M5X 1B8
CA
100 King St. West
Toronto, ON M5X 1B8
CA
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |